Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -101.94% | -296.02% | 277.69% | 12.05% | -286.61% |
| Total Depreciation and Amortization | -54.95% | 3.74% | -9.32% | -12.59% | -49.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 739.77% | -23.57% | 162.43% | 6.35% | 108.19% |
| Change in Net Operating Assets | -113.55% | 256.51% | -433.28% | 172.13% | -133.18% |
| Cash from Operations | -236.46% | 7,322.58% | -90.77% | 111.51% | -621.25% |
| Capital Expenditure | 100.00% | 33.33% | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 100.00% | 33.33% | -- | 100.00% | 96.49% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 95.58% | -79.14% | -13.93% | 1.61% | -83.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 310.04% | -71.72% | -18.85% | -109.53% | 1,996.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -216.27% | 787.40% | -384.78% | 125.48% | -198.10% |